Kuros Biosciences AG (KURN.SW) SIX

24.60

+0.44(+1.82%)

Updated at September 30 09:59AM

Currency In CHF

Valuation

Market Cap794.19M
Enterprise Value778.52M
P/E Ratio-213.34
PEG Ratio-4.1
Price/Sales Ratio12.56
Price/Book Ratio15.58
Enterprise/Revenue12.36
Enterprise/EBITDA2,012.17

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterDecember 31, 2024

Profitability

Profit Margin-0.06
Operating Margin-0

Management Effectiveness

Return On Assets-0.05
Return On Equity-0.07

Income Statement

Revenue75.56M
Revenue/Share2.03
Gross Profit62.03M
EBITDA-561,000
Net Income-3.72M
Diluted EPS-0.1

Balance Sheet

Total Cash17.46M
Total Cash/Share0.47
Total Debt1.79M
Total Debt/Equity0.03
Current Ratio2.14
Book Value Per Share1.58

Price History

52-Week Change34.28
52-Week High32
52-Week Low14
Moving Average 50 Days26.1
Moving Average 200 Days23.79

Statistics

Average Volume232,049
Shares Outstanding38.59M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor217:200
Last Split DateOctober 08, 2020